For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of Vyndamax and the formulated version represents a genuine breakthrough . These innovative therapies protect the transthyretin protein, slowing its damaging build-up and reducing the burden of the disease . Individuals are now seeing po… Read More